These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8621857)

  • 21. Cell-mediated immunity in bronchial asthma evaluated by purified protein derivative- and Candida albicans-skin reaction.
    Mitsunobu F; Kitani H; Okazaki M; Mifune T; Okano T; Honke N; Tanizaki Y
    Acta Med Okayama; 1993 Aug; 47(4):229-32. PubMed ID: 8213216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of high dose inhaled corticosteroids on cell mediated immunity in patients with asthma.
    Lee C; Klaustermeyer WB
    Allergol Immunopathol (Madr); 2012; 40(2):100-3. PubMed ID: 22236734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic bioactivity profiles of oral prednisolone and nebulized budesonide in adult asthmatics.
    Wilson AM; McFarlane LC; Lipworth BJ
    Chest; 1998 Oct; 114(4):1022-7. PubMed ID: 9792571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform.
    Sousa AR; Lane SJ; Cidlowski JA; Staynov DZ; Lee TH
    J Allergy Clin Immunol; 2000 May; 105(5):943-50. PubMed ID: 10808175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering.
    van den Berge M; Arshad SH; Ind PW; Magnussen H; Hamelmann E; Kanniess F; Postma DS
    Respir Med; 2009 Aug; 103(8):1216-23. PubMed ID: 19297141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of relationships between tuberculin responses and development of adult asthma with rhinitis and atopy.
    Li J; Zhou Z; An J; Zhang C; Sun B; Zhong N
    Chest; 2008 Jan; 133(1):100-6. PubMed ID: 18187743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.
    Kishiyama JL; Valacer D; Cunningham-Rundles C; Sperber K; Richmond GW; Abramson S; Glovsky M; Stiehm R; Stocks J; Rosenberg L; Shames RS; Corn B; Shearer WT; Bacot B; DiMaio M; Tonetta S; Adelman DC
    Clin Immunol; 1999 May; 91(2):126-33. PubMed ID: 10227804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of tuberculosis and positive tuberculin skin tests in a steroid-treated asthmatic population.
    Schatz M; Patterson R; Kloner R; Falk J
    Ann Intern Med; 1976 Mar; 84(3):261-5. PubMed ID: 1259260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of oral and inhaled corticosteroid on lymphocyte beta2-adrenoceptor function in asthmatic patients.
    Tan KS; McFarlane LC; Lipworth BJ
    Br J Clin Pharmacol; 1997 Dec; 44(6):565-8. PubMed ID: 9431832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care.
    Levy ML; Stevenson C; Maslen T
    Thorax; 1996 Nov; 51(11):1087-92. PubMed ID: 8958890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypothalamic-pituitary-adrenal axis in corticosteroid-resistant bronchial asthma.
    Lane SJ; Atkinson BA; Swaminathan R; Lee TH
    Am J Respir Crit Care Med; 1996 Feb; 153(2):557-60. PubMed ID: 8564097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients.
    Taylor DA; Jensen MW; Kanabar V; Engelstätter R; Steinijans VW; Barnes PJ; O'Connor BJ
    Am J Respir Crit Care Med; 1999 Jul; 160(1):237-43. PubMed ID: 10390406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of prednisolone in asthmatic patients with a poor response to steroid treatment.
    Mortimer O; Grettve L; Lindström B; Lönnerholm G; Zetterström O
    Eur J Respir Dis; 1987 Nov; 71(5):372-9. PubMed ID: 3443161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of betamethasone on airway obstruction and bronchial response to salbutamol in prednisolone resistant asthma.
    Grandordy B; Belmatoug N; Morelle A; De Lauture D; Marsac J
    Thorax; 1987 Jan; 42(1):65-71. PubMed ID: 3303425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent airway T-lymphocyte activation in chronic corticosteroid-treated symptomatic asthma.
    Redington AE; Wilson JW; Walls AF; Madden J; Djukanovic R; Holgate ST; Howarth PH
    Ann Allergy Asthma Immunol; 2000 Dec; 85(6 Pt 1):501-7. PubMed ID: 11152173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Auranofin in the treatment of steroid dependent asthma: a double blind study.
    Nierop G; Gijzel WP; Bel EH; Zwinderman AH; Dijkman JH
    Thorax; 1992 May; 47(5):349-54. PubMed ID: 1609377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma.
    Chaudhuri R; Livingston E; McMahon AD; Thomson L; Borland W; Thomson NC
    Am J Respir Crit Care Med; 2003 Dec; 168(11):1308-11. PubMed ID: 12893649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin test responsiveness to four new tuberculins in patients with chronic obstructive airways disease receiving short term high doses of, or long term maintenance treatment with, prednisolone: clinical appearances and histometric studies.
    Lowe JG; Beck JS; Gibbs JH; Brown RA; Potts RC; Grange JM; Stanford JL
    J Clin Pathol; 1987 Jan; 40(1):42-9. PubMed ID: 3493262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose response of patients to oral corticosteroid treatment during exacerbations of asthma.
    Webb JR
    Br Med J (Clin Res Ed); 1986 Apr; 292(6527):1045-7. PubMed ID: 3083995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study.
    Castro M; Wenzel SE; Bleecker ER; Pizzichini E; Kuna P; Busse WW; Gossage DL; Ward CK; Wu Y; Wang B; Khatry DB; van der Merwe R; Kolbeck R; Molfino NA; Raible DG
    Lancet Respir Med; 2014 Nov; 2(11):879-890. PubMed ID: 25306557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.